Authors


Aditya Shah, MBBS

Latest:

Infectious Diseases Provider Role in Extracorporeal Membrane Oxygenation Infections

There has been an emergence of extracorporeal membrane oxygenation-associated infections. Here is a review of how to define them and clinical management of this heterogeneous syndrome.


Tori Whitacre Martonicz

Latest:

Advancing Viral Disease Treatment of Recurrent Genital Herpes, Hepatitis B and D Viruses

The healthcare sector currently faces an unmet need in treating herpesviruses, hepatitis B, and hepatitis D, which could significantly improve patient outcomes. Addressing this involves considering the necessary steps and understanding the challenges pharmaceutical companies encounter as they work towards developing treatments for these conditions.


Jonathan H. Ryder, MD

Latest:

Updates and Controversies in Necrotizing Soft Tissue Infections

Changes in microbiology and antimicrobial resistance patterns warrant reevaluation of our current therapies for this condition.


Armand Butera

Latest:

CDC Influenza Surveillance Weekly Report

Clinical and public health laboratories reported increased influenza virus detections over the past few weeks, but US cases remains comparatively low to previous flu seasons.


Amy Carenza, BBA

Latest:

Infection Control: AP Technology's Impact on Reducing HAIs and AMR Pathogens

Deborah Birx, MD, and Amy Carenza, BBA, highlight the targeting of multidrug-resistant organisms and tracking of infection trends without increasing staffing needs.


Tiana Patriarca, PharmD candidate

Latest:

Linezolid Coadministration With Medications for Opioid Use Disorder: A Serotonin Toxicity Tightrope?

This study characterized the incidence of serotonin syndrome and identified contributing risk factors with combined medications for opioid use disorder (MOUD) and linezolid use.


Thein Myint, MBBS

Latest:

Sorry Ganciclovir, You’re Just Not the One for Me

Important clinical considerations to know about resistant CMV infections.


Laura L. Bio, PharmD, BCPS, BCIDP

Latest:

The Role of Pharmacists in the World of Pediatric Antimicrobial Stewardship

The limitation in the number of pediatric-specific guidelines by professional organizations, and results from large randomized clinical trials, may place an additional emphasis on literature evaluation skills for pediatric ASP pharmacists.


Jillian Walters, PharmD, MPH

Latest:

The ART of Implementing an Antiretroviral Stewardship Program

By addressing ART-related medication errors and increasing linkage to care, antiretroviral stewardship programs can improve management of inpatients with HIV.


Rakhshanda Akram, MD

Latest:

What's in the Pipeline?

A look at up-and-coming HIV drugs in development.



SHELLEY HANKINS, MD

Latest:

Cryptosporidium: A Potentially Fatal Cause of Diarrhea in a Heart Transplant Recipient

Expanding the differential for diarrhea beyond Clostridium difficile.


Dava Stewart

Latest:

Using Deep Sequencing Technology to Detect HCV Resistant Variants

A research team from the Netherlands turns to deep sequencing technology to detect hepatitis C virus resistant variants.



Contagion&reg Editorial Staff

Latest:

The ID Pipeline: Drug Development Debrief | Week of September 13, 2020

A quick debrief of the week’s top FDA approvals, FDA authorizations, or other infectious disease pipeline developments from the past week.


Jose A. Vazquez, MD

Latest:

Medical Importance of Microbial Biofilms in the Management of Infectious Diseases

Biofilms are an emerging clinical problem despite the fact that most clinicians don’t even think of biofilms when managing infections.


Brandon May

Latest:

MSM Who Use Mobile Apps for Sex More Likely to Have STIs

Men who have sex with men who seek out sexual partners online are more likely to report sexually transmitted infections, including syphilis, gonorrhea, and chlamydia.


Debra Goff, PharmD, FCCP

Latest:

The Significance of Antimicrobial Stewardship in Dentistry

Debra Goff, PharmD, discusses her advocacy around this topic and bringing the stewardship message to dentists about how antibiotic prescribing practices have changed and getting them to recalibrate their thinking and actions in their field.


Amanda Binkley, PharmD, AAHIVP

Latest:

Treatment as Prevention: A Comprehensive Approach to Hepatitis C Virus in Persons Who Inject Drugs

With IV drug use accounting for 60% of new infections, treatment for individuals in this population is necessary to stave off new infections.


Daniela Dimarco, MD

Latest:

Optimal Vancomycin Dosing in Obese Patients: Moving Toward the AUC

This In the Literature piece explores if we can mitigate some of the adverse reactions that are being seen in obese patients who receive vancomycin through AUC-dosing.



Ilia Rochlin, PhD

Latest:

Tick, Tick, Tick: Vector-Borne Diseases Ramp Up

Infections transmitted by these bloodsucking species are on the rise worldwide.



Amesh A. Adalja, MD, FIDSA

Latest:

Will Pennsylvania Proposal Sanction Improper Treatment of Lyme Disease?

Amesh A. Adalja, MD, FIDSA argues that a bill being considered in the Pennsylvania state legislature will ultimately result in increased antibiotic resistance and will set back the clock for finding appropriate treatments for Lyme disease.


Lori Strazdas, MPH

Latest:

Manual Surface Disinfectants Must Continue to Evolve to Meet Changing Health Care Needs

Many health care facilities are looking to expand the use of broad-spectrum sporicidal disinfectants beyond patient isolation rooms to better address the role of the environment in pathogen transmission and acquisition.


Contagion Editorial Team

Latest:

The Latest in Clostridioides difficile Research and News

Here is a recap of the latest happenings during C diff awareness month.


Dimple Patel, PharmD

Latest:

CREating New Strategies for the Treatment of Resistant Gram-Negative Infections

This was the first study to compare clinical outcomes in carbapenemase-producing (CP-CRE) and non–carbapenemase-producing (nCP-CRE) infections.


Khalid Eljaaly, PharmD, BCPS, CAPP

Latest:

Changes in Therapy Guideline for Nosocomial Pneumonia

Contagion® Editorial Advisory Board member, Khalid Eljaaly, PharmD, BCPS, CAPP, discusses key updates in the Infectious Diseases Society of America and the American Thoracic Society recommendations.


Kerry Lengyel

Latest:

NIH Awards $4.8 Million to University to Fight Potentially Fatal Fungal Infection

The National Institutes of Health has awarded a 4-year, $4.8 million grant to the University of Arizona to speed up the development of delta-CPS1, a vaccine candidate to fight valley fever.


Lisa Dumkow, PharmD, BCPS, BCIDP

Latest:

Best Practices for Getting Young Clinicians into Research

This time of year means new trainees will begin their careers and are excited to take on research projects. However, they may have limited to no experience in this area. Here is an opportunity to give them structure and guidance when committing to longitudinal trainee research.

© 2024 MJH Life Sciences

All rights reserved.